Attributable cost of methicillin resistance: An issue that is difficult to evaluate

Abstract

Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware. © 2006 BioMed Central Ltd.